Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 4 | 13 | 0,00 % | ||
| AGIOS | 2 | 8 | -0,95 % | ||
| BIOMARIN PHARMACEUTICAL | 1 | 12 | -0,33 % | ||
| CORMEDIX | 1 | 10 | -1,96 % | ||
| INSMED | 1 | 7 | +0,26 % | ||
| GILEAD SCIENCES | 1 | 5 | -0,77 % | ||
| EDGEWISE THERAPEUTICS | 1 | 2 | -3,41 % | ||
| COLLEGIUM PHARMACEUTICAL | 1 | 1 | 0,00 % | ||
| TEMPUS AI | 1 | 1 | 0,00 % | ||
| VANDA PHARMACEUTICALS | 1 | - | +1,74 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Omeros scores its first-ever FDA nod as stem cell transplant drug Yartemlea approved | 5 | FiercePharma | ||
| Fr | Hedge Fund and Insider Trading News: Ken Griffin, Ray Dalio, Warren Buffett, Toms Capital, Ken Fisher, Pershing Square, Amylyx Pharmaceuticals Inc (AMLX), NVIDIA Corp (NVDA), and More | 12 | Insider Monkey | ||
| Fr | Collegium Pharmaceutical: Aktie markiert Rekordhoch bei 49,92 USD | 1 | Investing.com Deutsch | ||
| Fr | Vanda Pharmaceuticals Stock Rallies on FDA Filing | 12 | Schaeffer's Research | ||
| Fr | Eilmeldung am Abend: BIONTECH SE ADR steht auf der Kippe! | 12 | Maximilian Berger | ||
| Fr | Stifel reiterates Buy rating on Xenon Pharmaceuticals stock amid competitor setback | 3 | Investing.com | ||
| Fr | Weekly Buzz: FDA OKs Roche's Lunsumio VELO; It's No For Tolbrutinib; BioMarin, Sanofi Open Wallets | 376 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - In a holiday-shortened week, the biotech sector saw a wave of FDA approvals, strategic acquisitions, and key clinical trial readouts - alongside several setbacks... ► Artikel lesen | |
| Fr | Why Did Edgewise Therapeutics Jump 25%+ On Wednesday? | 1 | Forbes | ||
| Fr | Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? | 4 | Zacks | ||
| Fr | BofA Securities raises Agios Pharma stock price target on FDA approval | 5 | Investing.com | ||
| Fr | FDA-Zulassung für Thalassämie-Medikament: BofA Securities hebt Kursziel für Agios Pharma an | 8 | Investing.com Deutsch | ||
| Fr | How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up | 6 | Zacks | ||
| Fr | Biontech mit SONDERMELDUNG! | Hebelschein-Spekulant | |||
| Fr | Gilead Sciences to acquire Repare's RP-3467 | 4 | Pharmaceutical Technology | ||
| Do | Hedge Fund and Insider Trading News: Steve Cohen, Ray Dalio, Warren Buffett, Alan Howard, Scott Bessent, Saba Capital Management, Halozyme Therapeutics Inc (HALO), Epsilon Energy Ltd (EPSN), and More | 9 | Insider Monkey | ||
| Do | Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger | 17 | Insider Monkey | ||
| Do | Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal | 2 | Manila Times | ||
| Do | Regeneron Pharmaceuticals: Aktie auf Comeback-Kurs | 691 | sharedeals.de | Die Aktie von Regeneron Pharmaceuticals konnte sich seit unserer positiven Einschätzung Anfang August hervorragend entwickeln und rund 50% Kursgewinn verzeichnen. Trotz Gegenwinds durch auslaufende... ► Artikel lesen | |
| Do | Sanofi übernimmt Dynavax für 2,2 Mrd USD an Heilig Abend | 18 | Startbase | ||
| Do | Jacobio, AstraZeneca ink cancer drug deal | 2 | China Daily |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .